Miltefosine
Description du produit
Miltefosine is a pharmaceutical substance for the treatment of parasite-induced leishmaniasis. It is used in human and veterinary medicines and is taken orally in the form of tablets.
Comprehensive documentation for drug registration of Miltefosine can be provided by Biesterfeld as referred.
| CAS-No. | Regulatory | Monograph |
|---|---|---|
| 58066-85-6 | ASMF | IH |
Tradename(s)
Miltefosine (Antileishmanial)
Disponibilité pays
Disponible dans le monde entier
Interlocuteur
Georges Bertagne
General Manager
Interlocuteur
Brigitte Favre Bonnefoy
Head of Sales